60
Participants
Start Date
March 24, 2025
Primary Completion Date
April 30, 2028
Study Completion Date
April 30, 2029
Blood and Tissue Collection
Blood samples, and tissue samples will be collected from the participants, and used to determine whether circulating tumor DNA (ctDNA) testing can help monitor treatment in patients with CSCC, and to determine how ctDNA levels change in patients.
RECRUITING
Massachusetts Eye and Ear, Boston
Haystack Oncology, Inc.
UNKNOWN
Massachusetts General Hospital
OTHER
Massachusetts Eye and Ear Infirmary
OTHER